Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 2Phase 3 1

Status

Completed 5Withdrawn 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6Genitourinary 1

Conditions

Breast Neoplasms 6

Interventions

Cyclophosphamide 423Trastuzumab 414Paclitaxel 375Docetaxel 314Capecitabine 266Letrozole 262Carboplatin 257Doxorubicin 213Tamoxifen 184Fulvestrant 176Epirubicin 176Radiotherapy 171Anastrozole 164pembrolizumab 152pertuzumab 147Surveys and Questionnaires 146Exercise 142exemestane 128Vinorelbine 127palbociclib 124Bevacizumab 123Magnetic Resonance Spectroscopy 120Blood Specimen Collection 120Drug Therapy 106Albumin-Bound Paclitaxel 105Gemcitabine 99130-nm albumin-bound paclitaxel 98pyrotinib 92eribulin 90Biopsy 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Alloderm × Breast × Clear all
NCT00956384 2024-12-05

AllodermRCT

University Health Network, Toronto

Phase NA Completed
198 enrolled 9 charts
Breast

Breast Neoplasms

NCT00639106 2018-10-03

Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
70 enrolled
Breast

Breast Neoplasms

NCT02372305 2018-07-18

Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery

University of Arkansas

Phase 4 Withdrawn
Breast

Breast Neoplasms

NCT00872859 2017-05-18

The BREASTrial:Breast Reconstruction Evaluation Using Acellular Dermal Matrix as a Sling Trial

University of Utah

Phase 4 Completed
128 enrolled
Breast

Breast Neoplasms

NCT01561287 2016-05-11

A Comparison of Dermal Autograft to AlloDerm in Breast Reconstruction

University of Kentucky

Phase 4 Completed
48 enrolled
Breast

Breast Neoplasms

NCT01027637 2013-09-06

Regenerative Tissue Matrix for Breast Reconstruction

Henry Ford Health System

Phase NA Completed
33 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡